Search for other papers by Hana Vítková in
Google Scholar
PubMed
Department of Gynaecology, Obstetrics and Neonatology, First Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic
Search for other papers by Kateřina Anderlová in
Google Scholar
PubMed
Search for other papers by Jan Krátký in
Google Scholar
PubMed
Search for other papers by Radovan Bílek in
Google Scholar
PubMed
Search for other papers by Drahomíra Springer in
Google Scholar
PubMed
Search for other papers by Felix Votava in
Google Scholar
PubMed
Search for other papers by Tomáš Brutvan in
Google Scholar
PubMed
Search for other papers by Adéla Krausová in
Google Scholar
PubMed
Search for other papers by Kristýna Žabková in
Google Scholar
PubMed
Search for other papers by Eliška Potluková in
Google Scholar
PubMed
Search for other papers by Jan Jiskra in
Google Scholar
PubMed
tolerance test (OGTT) performed in the second trimester of pregnancy, and 98 pregnant women with negative OGTT as a control group were included in the study. Forty-two women treated with levothyroxine were excluded from the analysis; therefore, 195 women
Search for other papers by Yi Chen in
Google Scholar
PubMed
Search for other papers by Wen Zhang in
Google Scholar
PubMed
Search for other papers by Chi Chen in
Google Scholar
PubMed
Search for other papers by Yuying Wang in
Google Scholar
PubMed
Search for other papers by Ningjian Wang in
Google Scholar
PubMed
Search for other papers by Yingli Lu in
Google Scholar
PubMed
recommended for use in epidemiological studies as reference markers of bone formation and resorption ( 8 ). Several reports have suggested that anti-thyroid dysfunction treatment may influence the bone metabolism. Long-term levothyroxine substitution therapy
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Signe Kirkegaard in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Nanna Maria Uldall Torp in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
H Chi H Zeng L Xiao W Wang Y Li R Liu P Wang C Tian Q , et al. Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer a
Search for other papers by Ruth Percik in
Google Scholar
PubMed
Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Search for other papers by Kate Young in
Google Scholar
PubMed
Royal Marsden Hospital, London, UK
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
) ( Fig. 2 ). Replacement with levothyroxine and sex hormones may be required as per standard approaches in time, although morning cortisol should always be checked and replacement initiated prior to starting levothyroxine. Whilst there is some evidence of
Search for other papers by Muthiah Subramanian in
Google Scholar
PubMed
Search for other papers by Manu Kurian Baby in
Google Scholar
PubMed
Search for other papers by Krishna G Seshadri in
Google Scholar
PubMed
persistent low FT 4 and elevated TSH and had been started on levothyroxine replacement. Euthyroidism was defined as normal FT 4 , TSH levels without levothyroxine. Time taken to achieve successful cure (TC) was defined as the time (in days) from the date of
Search for other papers by Jiashu Li in
Google Scholar
PubMed
Search for other papers by Aihua Liu in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Haixia Liu in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Weiwei Wang in
Google Scholar
PubMed
Search for other papers by Cheng Han in
Google Scholar
PubMed
Search for other papers by Xinyi Wang in
Google Scholar
PubMed
Search for other papers by Yuanyuan Zhang in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
-pregnancy TSH levels would increase the risks for spontaneous miscarriage. Early levothyroxine treatment, then, may reduce the risk of miscarriage ( 16 ). Table 5 Odds of miscarriage by serum TSH levels in the first trimester stratified by quintiles
Search for other papers by Maria Stelmachowska-Banaś in
Google Scholar
PubMed
Search for other papers by Izabella Czajka-Oraniec in
Google Scholar
PubMed
, but only after HC replacement has been implemented to avoid precipitating an adrenal crisis ( 33 , 56 ). We recommend starting with a low dose of levothyroxine (25–50 μg/day), especially in older patients and those with coronary artery disease, and
Search for other papers by Magdalena Lech in
Google Scholar
PubMed
Search for other papers by Ruvini Ranasinghe in
Google Scholar
PubMed
Faculty of Life Sciences and Medicine, School of Life Course Sciences, King’s College London, London, UK
Search for other papers by Royce P Vincent in
Google Scholar
PubMed
Search for other papers by David R Taylor in
Google Scholar
PubMed
Search for other papers by Lea Ghataore in
Google Scholar
PubMed
Search for other papers by James Luxton in
Google Scholar
PubMed
Quebec Heart and Lung Institute, Laval University, Quebec, Canada
Search for other papers by Fannie Lajeunesse-Trempe in
Google Scholar
PubMed
Search for other papers by Pia Roser in
Google Scholar
PubMed
Search for other papers by Eftychia E Drakou in
Google Scholar
PubMed
Search for other papers by Ling Ling Chuah in
Google Scholar
PubMed
Barts and the London School of Medicine, Centre for Endocrinology, William Harvey Institute, London, UK
Neuroendocrine Tumour Unit, Royal Free Hospital, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Search for other papers by Simon J B Aylwin in
Google Scholar
PubMed
Obesity, Type 2 Diabetes and Immunometabolism Research Group, School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Course Sciences, King’s College London, London, UK
Division of Reproductive Health, Warwick Medical School, University of Warwick, Coventry, UK
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
of mitotane therapy had been associated with a central hypothyroidism prevalence of 73.3%. This accentuates the importance of regular thyroid function investigations to assess individuals’ needs for levothyroxine therapy ( 7 , 14 ). The pregnant
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
NAFLD should be considered for individuals with hypothyroidism, in particular when they are also overweight or obese. Levothyroxine administration has been shown to be associated with reduction of the BMI and the level of serum lipids, thus suggesting
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
from the high rT3/T3 ratio seen in pregnant women ( 13 ). The activity of DIO3 is considered part of the reason why athyreotic women need a 50% increase in their Levothyroxine dose by the time they become pregnant ( 14 ). Thus, the activity of DIO3 is